16-21691609-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_144672.4(OTOA):c.661G>A(p.Asp221Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D221V) has been classified as Uncertain significance.
Frequency
Consequence
NM_144672.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 22Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_144672.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTOA | NM_144672.4 | MANE Select | c.661G>A | p.Asp221Asn | missense | Exon 9 of 29 | NP_653273.3 | ||
| OTOA | NM_001161683.2 | c.424G>A | p.Asp142Asn | missense | Exon 4 of 24 | NP_001155155.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTOA | ENST00000646100.2 | MANE Select | c.661G>A | p.Asp221Asn | missense | Exon 9 of 29 | ENSP00000496564.2 | ||
| OTOA | ENST00000388958.8 | TSL:1 | c.661G>A | p.Asp221Asn | missense | Exon 8 of 28 | ENSP00000373610.3 | ||
| OTOA | ENST00000286149.8 | TSL:5 | c.661G>A | p.Asp221Asn | missense | Exon 8 of 28 | ENSP00000286149.4 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152074Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251230 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461588Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727084 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74288 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Asp221Asn variant in OTOA has not been previously reported in individuals with hearing loss, but has been identified in 7/ 276964 chromosomes by the Genom e Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs14269 3996). Although this variant has been seen in the general population, its freque ncy is not high enough to rule out a pathogenic role. Computational prediction t ools and conservation analyses do not provide strong support for or against an i mpact to the protein. In summary, the clinical significance of the p.Asp221Asn v ariant is uncertain.
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at